Comparing treatments for a failing surgical aortic valve
Part of Heart & circulation clinical trials.
This trial compares two ways to treat a failing aortic valve that was replaced with a tissue valve during surgery: another surgical replacement or a less invasive catheter-based valve-in-valve procedure. It is for people with low to intermediate surgical risk who are between 18 and 75 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a surgically placed aortic valve that is now failing (narrowing or leaking).
- You are between 18 and 75 years old.
- Your risk of death from surgery is less than 8% (low to intermediate risk).
- Your heart team thinks both options (replacing the valve again or doing a valve-in-valve procedure) are reasonable for you.
- You do not have an active infection in your heart valve, and you do not need other heart valve surgery at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to fix a previously placed TAVR heart valve that is no longer working well: surgically removing it (TAVR-explant) or placing a new TAVR valve inside it (redo-TAVR). It is for people who are having symptoms because their valve is failing.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
This trial compares a new less-invasive valve replacement (Trilogy TAVR) with standard open-heart surgery for people with significant aortic regurgitation. It aims to see which treatment works better for patients who are eligible for both procedures.
This trial is for people who have already had a TAVI (a minimally invasive aortic valve replacement) and now need a second procedure because the valve is failing. The study will test how well a redo TAVI works to fix the failing valve.
Hear when a new Degenerative Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.